CBD tested as potential Game-Changer in fight against opioid addiction
NCT ID NCT06940674
Summary
This study is testing whether cannabidiol (CBD), a non-intoxicating compound from cannabis, can help people with opioid addiction stay off illicit drugs. It will involve 450 adults who are already receiving standard medication treatment (methadone or buprenorphine). Participants will take either CBD or a placebo pill twice daily for 24 weeks to see if CBD reduces drug cravings and relapse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER (OUD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CODA Treatment Recovery
RECRUITINGPortland, Oregon, 97214, United States
Contact Email: •••••@•••••
Contact
-
Icahn School of Medicine at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.